American Portfolios Advisors Nova Bay Pharmaceuticals, Inc. Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

A detailed history of American Portfolios Advisors transactions in Nova Bay Pharmaceuticals, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 2,935 shares of NBY stock, worth $1,995. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,935
Holding current value
$1,995
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023
BUY
$0.11 - $147.37 $322 - $432,530
2,935 New
2,935 $323,000

Others Institutions Holding NBY

# of Institutions
1
Shares Held
2.94K
Call Options Held
0
Put Options Held
0
View Full List

About NovaBay Pharmaceuticals, Inc.

NBY Quotes by TradingView
  • Ticker NBY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,988,400
  • Market Cap $44.2M
  • Description
  • NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and Phase...
More about NBY
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email